Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04632641 · ClinicalTrials.gov registry record · NA
Suture Closure AFtEr VEIN Access for Cardiac Procedures (SAFE-VEIN) Trial
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 107
- Enrollment target
NCT04632641: Completed NA study, sponsored by Wake Forest University Health Sciences.
NCT04632641 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 107 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04632641, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 107 participants
- Enrollment target
Study Summary
Primary objective: To compare the safety and efficacy of closure strategies post venous access procedures. Hypothesis: We anticipate that the use of a venous closure device will decrease the time to hemostasis (TTH), time to ambulation (TTA) and time to discharge (TTD) compared to conventional methods of closure following venous access procedure.
Primary Outcome
The elapsed time between "device" removal and first observed and confirmed venous hemostasis
Interventions
- DEVICE Perclose ProGlide Suture-Mediated Closure System (SMC) - LARGE-BORE PROCEDURES
- OTHER Figure 8 Suture - LARGE-BORE PROCEDURES
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 107 participants |
| Start Date | 2021-04-23 |
| Est. Completion | 2023-12-31 |
| Phase | NA |
What the finished NCT04632641 record still lists
NCT04632641 is an interventional study that assigns participants to a tested intervention. The registered 107 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 2 interventions - of which Perclose ProGlide Suture-Mediated Closure System (SMC) - LARGE-BORE PROCEDURES is the first listed.
NCT04632641 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04632641 about?
NCT04632641 is a clinical study titled "Suture Closure AFtEr VEIN Access for Cardiac Procedures (SAFE-VEIN) Trial". Primary objective: To compare the safety and efficacy of closure strategies post venous access procedures. Hypothesis: We anticipate that the use of a venous closure device will decrease the time to hemostasis (TTH), time to ambulation (TTA) and time to discharge (TTD) compared to conventional meth...
What is the current status of trial NCT04632641?
This trial is currently completed. It is a NA study. The enrollment target is 107 participants. The study started on 2021-04-23. Estimated completion is 2023-12-31.
What interventions are being tested in trial NCT04632641?
The interventions under investigation include: Perclose ProGlide Suture-Mediated Closure System (SMC) - LARGE-BORE PROCEDURES (DEVICE), Figure 8 Suture - LARGE-BORE PROCEDURES (OTHER).
Who is sponsoring clinical trial NCT04632641?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04632641's enrollment target sits among peer trials
107 830th of 2000 higher than 1,171 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05491668 · 107 participants
Physiological Assessment of Severe Coronary Stenosis for Informing Planned PCI
- NCT06041594 · 107 participants · NA
Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)
- NCT06081426 · 107 participants · NA
Examining Neurobiological Mechanisms Underlying the Therapeutic Effect of the Ketogenic Diet in Bipolar Disorder (BD)
- NCT06527599 · 107 participants · NA
Screening in Trauma for Opioid Misuse Prevention - an Adaptive Intervention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI